Relationship between Body Mass Composition, Bone Mineral Density, Skin Fibrosis and 25(OH) Vitamin D Serum Levels in Systemic Sclerosis
Open Access
- 16 September 2015
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 10 (9) , e0137912
Abstract
A reduced bone mineral density (BMD) is observed in several rheumatic autoimmune diseases, including Systemic Sclerosis (SSc); nevertheless, data concerning the possible determinants of bone loss in this disease are not fully investigated. The aim of this study is to evaluate the relationship between BMD, body mass composition, skin sclerosis and serum Vitamin D levels in two subsets of SSc patients. 64 post-menopausal SSc patients, classified as limited cutaneous (lcSSc) or diffuse cutaneous (dcSSc) SSc, were studied. As control, 35 healthy post-menopausal women were recruited. Clinical parameters were evaluated, including the extent of skin involvement. BMD at lumbar spine, hip, femoral neck and body mass composition were determined by dual-energy X-ray absorptiometry. Serum calcium, phosphorus, alkaline phosphatase, urine pyridinium cross-links, intact parathyroid hormone and 25-hydroxyvitamin D (25OHD) were measured. BMD at spine, femoral neck and total hip was significantly lower in SSc patients compared to controls. In dcSSc subset, BMD at spine, femoral neck and total hip was significantly lower compared to lcSSc. No differences in both fat and lean mass were found in the three study groups even if patients with dcSSc showed a slightly lower total body mass compared to healthy controls. Total mineral content was significantly reduced in dSSc compared to both healthy subjects and lcSSc group. Hypovitaminosis D was observed both in healthy post-menopausal women and in SSc patients, but 25OHD levels were significantly lower in dcSSc compared to lcSSc and inversely correlated with the extent of skin thickness. These results support the hypothesis that the extent of skin involvement in SSc patients could be an important factor in determining low circulating levels of 25OHD, which in turn could play a significant role in the reduction of BMD and total mineral content.Keywords
This publication has 33 references indexed in Scilit:
- Vitamin D — Effects on Skeletal and Extraskeletal Health and the Need for SupplementationNutrients, 2013
- Vitamin D reduces the expression of collagen and key profibrotic factors by inducing an antifibrotic phenotype in mesenchymal multipotent cellsJournal of Endocrinology, 2008
- Evidence for association between vitamin D receptor BsmI polymorphism and type 1 diabetes in JapaneseJournal of Autoimmunity, 2008
- Hypovitaminosis D among rheumatology outpatients in clinical practiceRheumatology, 2008
- Vitamin D intake and risks of systemic lupus erythematosus and rheumatoid arthritis in womenAnnals of the Rheumatic Diseases, 2008
- Association between serum vitamin D metabolite levels and disease activity in patients with early inflammatory polyarthritisArthritis & Rheumatism, 2007
- Serum 25-Hydroxyvitamin D Levels and Risk of Multiple SclerosisJAMA, 2006
- The Rapid Assessment of Physical Activity (RAPA) Among Older Adults2006
- Estimation of optimal serum concentrations of 25-hydroxyvitamin D for multiple health outcomesThe American Journal of Clinical Nutrition, 2006
- Systemic sclerosis and bone loss: the role of the disease and body compositionScandinavian Journal of Rheumatology, 2006